Review of the Application of Nanovesicles and the Human Interstitial Fluid in Gastrointestinal Premalignant Lesion Detection, Diagnosis, Prognosis and Therapy

References

• Rentien AL, Lévy M, Copie-Bergman C, et al. Long-term course of precancerous lesions arising in patients with gastric MALT lymphoma. Dig Liver Dis. 2018;50(2):181–188. doi:10.1016/j.dld.2017.10.01429102522
   PubMedGoogle Scholar
• Li X, Li H, He X, et al. Spectrum- and time-resolved endogenous multiphoton signals reveal quantitative differentiation of premalignant and malignant gastric mucosa. Biomed Opt Express. 2018;9(2):453–471. doi:10.1364/BOE.9.00045329552386
   PubMedGoogle Scholar
• Benias PC, Wells RG, Sackey-Aboagye B, et al. Structure and distribution of an unrecognized interstitium in human tissues. Sci Rep. 2018;8(1):4947. doi:10.1038/s41598-018-23062-629588511
   PubMedGoogle Scholar
• Onsurathum S, Haonon O, Pinlaor P, et al. Proteomics detection of S100A6 in tumor tissue interstitial fluid and evaluation of its potential as a biomarker of cholangiocarcinoma. Tumour Biol. 2018;40(4):1010428318767195. doi:10.1177/101042831876719529629840
   PubMedGoogle Scholar
• Zhu Q, Heon M, Zhao Z, et al. Microfluidic engineering of exosomes: editing cellular messages for precision therapeutics. Lab Chip. 2018;18(12):1690–1703. doi:10.1039/c8lc00246k29780982
   PubMed Web of Science ®Google Scholar
• Li P, Yao Q, Lü B, et al. Visible Light-induced supra-amphiphilic switch leads to transition from supramolecular nanosphere to nanovesicle activated by pillar[5]arene-based host-guest interaction. Macromol Rapid Commun. 2018;39(20):e1800133. doi:10.1002/marc.20180013329786904
   PubMedGoogle Scholar
• Danaei M, Dehghankhold M, Ataei S, et al. Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems. Pharmaceutics. 2018;10(2):E57. doi:10.3390/pharmaceutics1002005729783687
   PubMed Web of Science ®Google Scholar
• Sun B, Peng J, Wang S, et al. Applications of stem cell-derived exosomes in tissue engineering and neurological diseases. Rev Neurosci. 2018;29(5):531–546. doi:10.1515/revneuro-2017-005929267178
   PubMedGoogle Scholar
• Atay S, Wilkey DW, Milhem M, et al. Insights into the proteome of gastrointestinal stromal tumors-derived exosomes reveals new potential diagnostic biomarkers. Mol Cell Proteomics. 2018;17(3):495–515. doi:10.1074/mcp.RA117.00026729242380
   PubMed Web of Science ®Google Scholar
• Bhat A, Huan K, Cooks T, et al. Probing interactions between AuNPs/AgNPs and Giant Unilamellar Vesicles (GUVs) using hyperspectral dark-field microscopy. Int J Mol Sci. 2018;19(4):E1014. doi:10.3390/ijms1904101429597298
   PubMedGoogle Scholar
• Arenaccio C, Chiozzini C, Ferrantelli F, et al. Exosomes in therapy: engineering, pharmacokinetics and future applications. Curr Drug Targets. 2019;20(1):87–95. doi:10.2174/138945011966618052110040929779478
   PubMedGoogle Scholar
• Boyiadzis M, Whiteside TL. The emerging roles of tumor-derived exosomes in hematological malignancies. Leukemia. 2017;31(6):1259–1268. doi:10.1038/leu.2017.9128321122
   PubMed Web of Science ®Google Scholar
• Giusti I, Di Francesco M, Dolo V. Extracellular vesicles in glioblastoma: role in biological processes and in therapeutic applications. Curr Cancer Drug Targets. 2017;17(3):221–235. doi:10.2174/156800961666616081318295927528364
   PubMed Web of Science ®Google Scholar
• Zhang J, Hao N, Liu W, et al. In-depth proteomic analysis of tissue interstitial fluid for hepatocellular carcinoma serum biomarker discovery. Br J Cancer. 2017;117(11):1676–1684. doi:10.1038/bjc.2017.34429024941
   PubMed Web of Science ®Google Scholar
• Ludwig N, Whiteside TL. Potential roles of tumor-derived exosomes in angiogenesis. Expert Opin Ther Targets. 2018;22(5):409–417. doi:10.1080/14728222.2018.146414129634426
   PubMed Web of Science ®Google Scholar
• Lin LY, Yang L, Zeng Q, et al. Tumor-originated exosomal lncUEGC1 as a circulating biomarker for early-stage gastric cancer. Mol Cancer. 2018;17(1):84. doi:10.1186/s12943-018-0834-929690888
   PubMed Web of Science ®Google Scholar
• Wang J, Liu Y, Sun W, et al. Plasma exosomes as novel biomarker for the early diagnosis of gastric cancer. Cancer Biomark. 2018;21(4):805–812. doi:10.3233/CBM-17073829400660
   PubMed Web of Science ®Google Scholar
• McMullen JRW, Selleck M, Wall NR, et al. Peritoneal carcinomatosis: limits of diagnosis and the case for liquid biopsy. Oncotarget. 2017;8(26):43481–43490. doi:10.18632/oncotarget.1648028415645
   PubMedGoogle Scholar
• Zhang K, Du X, Yu K, et al. Application of novel targeting nanoparticles contrast agent combined with contrast-enhanced computed tomography during screening for early-phase gastric carcinoma. Exp Ther Med. 2018;15(1):47–54. doi:10.3892/etm.2017.538829387181
   PubMedGoogle Scholar
• Feng ST, Li H, Luo Y, et al. Molecular targeted magnetic resonance imaging of human colorectal carcinoma (LoVo) cells using novel superparamagnetic iron oxide- loaded nanovesicles: in vitro and in vivo studies. Curr Cancer Drug Targets. 2016;16(6):551–560. doi:10.2174/156800961666616060312361627262319
   PubMedGoogle Scholar
• Blanco VM, Latif T, Chu Z, et al. Imaging and therapy of pancreatic cancer with phosphatidylserine-targeted nanovesicles. Transl Oncol. 2015;8(3):196–203. doi:10.1016/j.tranon.2015.03.01126055177
   PubMedGoogle Scholar
• Yan L, Dong X, Gao J, et al. A novel rapid quantitative method reveals stathmin-1 as a promising marker for esophageal squamous cell carcinoma. Cancer Med. 2018;7(5):1802–1813. doi:10.1002/cam4.144929577639
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhang C, Zhang P, et al. Serum exosomal microRNAs combined with alpha-fetoprotein as diagnostic markers of hepatocellular carcinoma. Cancer Med. 2018;7(5):1670–1679. doi:10.1002/cam4.139029573235
   PubMed Web of Science ®Google Scholar
• Huang Z, Zhang L, Zhu D, et al. A novel serum microRNA signature to screen esophageal squamous cell carcinoma. Cancer Med. 2017;6(1):109–119. doi:10.1002/cam4.97328035762
   PubMed Web of Science ®Google Scholar
• Davis HW, Hussain N, Qi X. Detection of cancer cells using SapC-DOPS nanovesicles. Mol Cancer. 2016;15(1):33. doi:10.1186/s12943-016-0519-127160923
   PubMedGoogle Scholar
• Ding J, Feng M, Wang F, et al. Targeting effect of PEGylated liposomes modified with the Arg-Gly-Asp sequence on gastric cancer. Oncol Rep. 2015;34(4):1825–1834. doi:10.3892/or.2015.414226238930
   PubMedGoogle Scholar
• Hoshino I, Maruyama T, Fujito H, et al. Detection of peritoneal dissemination with near-infrared fluorescence laparoscopic imaging using a liposomal formulation of a synthesized indocyanine green liposomal derivative. Anticancer Res. 2015;35(3):1353–1359.25750285
   PubMed Web of Science ®Google Scholar
• Li S, Yao J, Xie M, et al. Exosomal miRNAs in hepatocellular carcinoma development and clinical responses. J Hematol Oncol. 2018;11(1):54. doi:10.1186/s13045-018-0579-329642941
   PubMedGoogle Scholar
• Pan JH, Zhou H, Zhao XX, et al. Role of exosomes and exosomal microRNAs in hepatocellular carcinoma: potential in diagnosis and antitumour treatments (Review). Int J Mol Med. 2018;41(4):1809–1816. doi:10.3892/ijmm.2018.338329328436
   PubMedGoogle Scholar
• Zhang H, Wang Y, Bai M, et al. Exosomes serve as nanoparticles to suppress tumor growth and angiogenesis in gastric cancer by delivering hepatocyte growth factor siRNA. Cancer Sci. 2018;109(3):629–641. doi:10.1111/cas.1348829285843
   PubMed Web of Science ®Google Scholar
• George J, Yan IK, Patel T. Nanovesicle-mediated delivery of anticancer agents effectively induced cell death and regressed intrahepatic tumors in athymic mice. Lab Invest. 2018;98(7):895–910. doi:10.1038/s41374-018-0053-429748614
   PubMedGoogle Scholar
• Borrelli DA, Yankson K, Shukla N, et al. Extracellular vesicle therapeutics for liver disease. J Control Release. 2018;273:86–98. doi:10.1016/j.jconrel.2018.01.02229373816
   PubMedGoogle Scholar
• Thapa RK, Ku SK, Choi HG, et al. Vibrating droplet generation to assemble zwitterion-coated gold-graphene oxide stealth nanovesicles for effective pancreatic cancer chemo-phototherapy. Nanoscale. 2018;10(4):1742–1749. doi:10.1039/c7nr07603g29308494
   PubMed Web of Science ®Google Scholar
• Sun ZP, Li AQ, Jia WH, et al. MicroRNA expression profiling in exosomes derived from gastric cancer stem-like cells. Oncotarget. 2017;8(55):93839–93855. doi:10.18632/oncotarget.2128829212193
   PubMedGoogle Scholar
• Tokuhisa M, Ichikawa Y, Kosaka N, et al. Exosomal miRNAs from peritoneum lavage fluid as potential prognostic biomarkers of peritoneal metastasis in gastric cancer. PLoS One. 2015;10(7):e0130472. doi:10.1371/journal.pone.013047226208314
   PubMed Web of Science ®Google Scholar
• Matsumura T, Sugimachi K, Iinuma H, et al. Exosomal microRNA in serum is a novel biomarker of recurrence in human colorectal cancer. Br J Cancer. 2015;113(2):275–281. doi:10.1038/bjc.2015.20126057451
   PubMed Web of Science ®Google Scholar
• Guo J, Fan KX, Xie LI, et al. Effect and prognostic significance of the KAI1 gene in human gastric carcinoma. Oncol Lett. 2015;10(4):2035–2042. doi:10.3892/ol.2015.360426622792
   PubMedGoogle Scholar
• Zheng NG, Mo SJ, Li JP, et al. Anti-CSC effects in human esophageal squamous cell carcinomas and Eca109/9706 cells induced by nanoliposomal quercetin alone or combined with CD 133 antiserum. Asian Pac J Cancer Prev. 2014;15(20):8679–8684. doi:10.7314/apjcp.2014.15.20.867925374189
   PubMedGoogle Scholar
• Wang B, Zhuang X, Deng ZB, et al. Targeted drug delivery to intestinal macrophages by bioactive nanovesicles released from grapefruit. Mol Ther. 2014;22(3):522–534. doi:10.1038/mt.2013.19023939022
   PubMed Web of Science ®Google Scholar
• Joshi N, Saha R, Shanmugam T, et al. Carboxymethyl-chitosan-tethered lipid vesicles: hybrid nanoblanket for oral delivery of paclitaxel. Biomacromolecules. 2013;14(7):2272–2282. doi:10.1021/bm400406x23721348
   PubMed Web of Science ®Google Scholar
• EL Andaloussi S, Andaloussi S, Mäger I, et al. Extracellular vesicles: biology and emerging therapeutic opportunities. Nat Rev Drug Discov. 2013;12(5):347–357. doi:10.1038/nrd397823584393
   PubMed Web of Science ®Google Scholar
• Fujie S, Matsubayashi H, Ishiwatari H, et al. Intraductal tubulopapillary epithelial proliferation associated with type 1 autoimmune pancreatitis. J Gastrointestin Liver Dis. 2018;27(1):83–87. doi:10.15403/jgld.2014.1121.271.fuj29557419
   PubMedGoogle Scholar
• Liang L, Fanzong L, Peixi Z, et al. Plexiform angiomyxoid myofibroblastic tumor of the stomach: a case report. Diagn Cytopathol. 2017;45(1):55–58. doi:10.1002/dc.2357227561459
   PubMedGoogle Scholar
• Reichel D, Curtis LT, Ehlman E, et al. Development of halofluorochromic polymer nanoassemblies for the potential detection of liver metastatic colorectal cancer tumors using experimental and computational approaches. Pharm Res. 2017;34(11):2385–2402. doi:10.1007/s11095-017-2245-928840432
   PubMedGoogle Scholar
• Atochina-Vasserman EN, Guo CJ, Abramova E, et al. Surfactant dysfunction and lung inflammation in the female mouse model of lymphangioleiomyomatosis. Am J Respir Cell Mol Biol. 2015;53(1):96–104. doi:10.1165/rcmb.2014-0224OC25474372
   PubMedGoogle Scholar
• Ura B, Di Lorenzo G, Romano F, et al. Interstitial fluid in gynecologic tumors and its possible application in the clinical practice. Int J Mol Sci. 2018;19(12):E4018. doi:10.3390/ijms1912401830545144
   PubMedGoogle Scholar
• Roma-Rodrigues C, Raposo LR, Cabral R, et al. Tumor microenvironment modulation via gold nanoparticles targeting malicious exosomes: implications for cancer diagnostics and therapy. Int J Mol Sci. 2017;18(1):E162. doi:10.3390/ijms1801016228098821
   PubMedGoogle Scholar
• García-Romero N, Carrión-Navarro J, Esteban-Rubio S, et al. DNA sequences within glioma-derived extracellular vesicles can cross the intact blood-brain barrier and be detected in peripheral blood of patients. Oncotarget. 2017;8(1):1416–1428. doi:10.18632/oncotarget.1363527902458
   PubMedGoogle Scholar
• Sun Y, Liu S, Qiao Z, et al. Systematic comparison of exosomal proteomes from human saliva and serum for the detection of lung cancer. Anal Chim Acta. 2017;982:84–95. doi:10.1016/j.aca.2017.06.00528734369
   PubMed Web of Science ®Google Scholar
• Ferguson Bennit HR, Gonda A, McMullen JRW, et al. Peripheral blood cell interactions of cancer-derived exosomes affect immune function. Cancer Microenviron. 2019;12(1):29–35. doi:10.1007/s12307-018-0209-129603062
   PubMedGoogle Scholar
• Li A, Zhang T, Zheng M, et al. Exosomal proteins as potential markers of tumor diagnosis. J Hematol Oncol. 2017;10(1):175. doi:10.1186/s13045-017-0542-829282096
   PubMedGoogle Scholar
• Reátegui E, van der Vos KE, Lai CP, et al. Engineered nanointerfaces for microfluidic isolation and molecular profiling of tumor-specific extracellular vesicles. Nat Commun. 2018;9(1):175. doi:10.1038/s41467-017-02261-129330365
   PubMedGoogle Scholar
• Berglund E, Daré E, Branca RM, et al. Secretome protein signature of human gastrointestinal stromal tumor cells. Exp Cell Res. 2015;336(1):158–170. doi:10.1016/j.yexcr.2015.05.00425983130
   PubMed Web of Science ®Google Scholar
• Wagner M, Wiig H. Tumor interstitial fluid formation, characterization, and clinical implications. Front Oncol. 2015;5:115. doi:10.3389/fonc.2015.0011526075182
   PubMed Web of Science ®Google Scholar
• Woo SR, Corrales L, Gajewski TF. Innate immune recognition of cancer. Annu Rev Immunol. 2015;33:445–474. doi:10.1146/annurev-immunol-032414-11204325622193
   PubMed Web of Science ®Google Scholar
• Miao YB, Ren HX, Gan N, et al. A homogeneous and “off-on” fluorescence aptamer-based assay for chloramphenicol using vesicle quantum dot-gold colloid composite probes. Anal Chim Acta. 2016;929:49–55. doi:10.1016/j.aca.2016.04.06027251948
   PubMedGoogle Scholar
• Thakur A, Qiu G, Ng SP, et al. Direct detection of two different tumor-derived extracellular vesicles by SAM-AuNIs LSPR biosensor. Biosens Bioelectron. 2017;94:400–407. doi:10.1016/j.bios.2017.03.03628324860
   PubMed Web of Science ®Google Scholar
• Cheng Y, Liang P, Geng H, et al. A novel 19q13 nucleolar zinc finger protein suppresses tumor cell growth through inhibiting ribosome biogenesis and inducing apoptosis but is frequently silenced in multiple carcinomas. Mol Cancer Res. 2012;10(7):925–936. doi:10.1158/1541-7786.MCR-11-059422679109
   PubMedGoogle Scholar
• Han X, Bryson PD, Zhao Y, et al. Masked chimeric antigen receptor for tumor-specific activation. Mol Ther. 2017;25(1):274–284. doi:10.1016/j.ymthe.2016.10.01128129121
   PubMed Web of Science ®Google Scholar
• Dolor A, Szoka FC Jr. Digesting a path forward: the utility of collagenase tumor treatment for improved drug delivery. Mol Pharm. 2018;15(6):2069–2083. doi:10.1021/acs.molpharmaceut.8b0031929767984
   PubMedGoogle Scholar
• Rajagopal C, Harikumar KB. The origin and functions of exosomes in cancer. Front Oncol. 2018;8:66. doi:10.3389/fonc.2018.0006629616188
   PubMedGoogle Scholar
• Huang Y, Liu K, Li Q, et al. Exosomes function in tumor immune microenvironment. Adv Exp Med Biol. 2018;1056:109–122. doi:10.1007/978-3-319-74470-4_729754177
   PubMedGoogle Scholar
• Madhankumar AB, Mrowczynski OD, Patel SR, et al. Interleukin-13 conjugated quantum dots for identification of glioma initiating cells and their extracellular vesicles. Acta Biomater. 2017;58:205–213. doi:10.1016/j.actbio.2017.06.00228583903
   PubMed Web of Science ®Google Scholar
• Yamashita T, Takahashi Y, Nishikawa M, et al. Effect of exosome isolation methods on physicochemical properties of exosomes and clearance of exosomes from the blood circulation. Eur J Pharm Biopharm. 2016;98:1–8. doi:10.1016/j.ejpb.2015.10.01726545617
   PubMed Web of Science ®Google Scholar
• Urabe F, Kosaka N, Yoshioka Y, et al. The small vesicular culprits: the investigation of extracellular vesicles as new targets for cancer treatment. Clin Transl Med. 2017;6(1):45. doi:10.1186/s40169-017-0176-z29238879
   PubMedGoogle Scholar
• Vlodavsky I, Singh P, Boyango I, et al. Heparanase: from basic research to therapeutic applications in cancer and inflammation. Drug Resist Updat. 2016;29:54–75. doi:10.1016/j.drup.2016.10.00127912844
   PubMed Web of Science ®Google Scholar
• Vardaki I, Sanchez C, Fonseca P, et al. Caspase-3-dependent cleavage of Bcl-xL in the stroma exosomes is required for their uptake by hematological malignant cells. Blood. 2016;128(23):2655–2665. doi:10.1182/blood-2016-05-71596127742710
   PubMed Web of Science ®Google Scholar
• Barile L, Vassalli G. Exosomes: therapy delivery tools and biomarkers of diseases. Pharmacol Ther. 2017;174:63–78. doi:10.1016/j.pharmthera.2017.02.02028202367
   PubMed Web of Science ®Google Scholar
• Zhang P, Zhang L, Qin Z, et al. Genetically engineered liposome-like nanovesicles as active targeted transport platform. Adv Mater. 2018;30:7. doi:10.1002/adma.201705350
   Web of Science ®Google Scholar
• Tagalakis AD, Maeshima R, Yu-Wai-Man C, et al. Peptide and nucleic acid-directed self-assembly of cationic nanovehicles through giant unilamellar vesicle modification: targetable nanocomplexes for in vivo nucleic acid delivery. Acta Biomater. 2017;51:351–362. doi:10.1016/j.actbio.2017.01.04828110069
   PubMed Web of Science ®Google Scholar
• Fernandes E, Ferreira JA, Andreia P, et al. New trends in guided nanotherapies for digestive cancers: a systematic review. J Control Release. 2015;209:288–307. doi:10.1016/j.jconrel.2015.05.00325957905
   PubMed Web of Science ®Google Scholar
• Yang K, Liu Y, Liu Y, et al. Cooperative assembly of magneto-nanovesicles with tunable wall thickness and permeability for mri-guided drug delivery. J Am Chem Soc. 2018;140(13):4666–4677. doi:10.1021/jacs.8b0088429543442
   PubMedGoogle Scholar
• Chang L, Bertani P, Gallego-Perez D, et al. 3D nanochannel electroporation for high-throughput cell transfection with high uniformity and dosage control. Nanoscale. 2016;8(1):243–252. doi:10.1039/c5nr03187g26309218
   PubMedGoogle Scholar
• Ye Z, Zhang T, He W, et al. Methotrexate-loaded extracellular vesicles functionalized with therapeutic and targeted peptides for the treatment of glioblastoma multiforme. ACS Appl Mater Interfaces. 2018;10(15):12341–12350. doi:10.1021/acsami.7b1813529564886
   PubMed Web of Science ®Google Scholar
• Kooijmans SAA, Schiffelers RM, Zarovni N, et al. Modulation of tissue tropism and biological activity of exosomes and other extracellular vesicles: new nanotools for cancer treatment. Pharmacol Res. 2016;111:487–500. doi:10.1016/j.phrs.2016.07.00627394168
   PubMed Web of Science ®Google Scholar
• Tao SC, Guo SC, Zhang CQ. Modularized extracellular vesicles: the dawn of prospective personalized and precision medicine. Adv Sci (Weinh). 2018;5(2):1700449. doi:10.1002/advs.20170044929619297
   PubMedGoogle Scholar
• Wan S, He D, Yuan Y, et al. Chitosan-modified lipid nanovesicles for efficient systemic delivery of l-asparaginase. Colloids Surf B Biointerfaces. 2016;143:278–284. doi:10.1016/j.colsurfb.2016.03.04627022867
   PubMed Web of Science ®Google Scholar
• Hood JL. Post isolation modification of exosomes for nanomedicine applications. Nanomedicine (Lond). 2016;11(13):1745–1756. doi:10.2217/nnm-2016-010227348448
   PubMed Web of Science ®Google Scholar
• Deshpande NU, Jayakannan M. Cisplatin-stitched polysaccharide vesicles for synergistic cancer therapy of triple antagonistic drugs. Biomacromolecules. 2017;18(1):113–126. doi:10.1021/acs.biomac.6b0141128064505
   PubMedGoogle Scholar
• Aresh W, Liu Y, Sine J, et al. The morphology of self-assembled lipid-based nanoparticles affects their uptake by cancer cells. J Biomed Nanotechnol. 2016;12(10):1852–1863. doi:10.1166/jbn.2016.229229359898
   PubMedGoogle Scholar
• Cavin S, Wang X, Zellweger M, et al. Interstitial fluid pressure: a novel biomarker to monitor photo-induced drug uptake in tumor and normal tissues. Lasers Surg Med. 2017;49(8):773–780. doi:10.1002/lsm.2268728544068
   PubMedGoogle Scholar
• Gong MQ, Wu JL, Chen B, et al. Self-assembled polymer/inorganic hybrid nanovesicles for multiple drug delivery to overcome drug resistance in cancer chemotherapy. Langmuir. 2015;31(18):5115–5122. doi:10.1021/acs.langmuir.5b0054225927163
   PubMed Web of Science ®Google Scholar
• Tan DM, Fu JY, Wong FS, et al. Tumor regression and modulation of gene expression via tumor-targeted tocotrienol niosomes. Nanomedicine (Lond). 2017;12(20):2487–2502. doi:10.2217/nnm-2017-018228972460
   PubMedGoogle Scholar
• Feng C, Han X, Chi L, et al. Synthesis, characterization, and in vitro evaluation of TRAIL-modified, cabazitaxel -loaded polymeric micelles for achieving synergistic anticancer therapy. J Biomater Sci Polym Ed. 2018;29(14):1729–1744. doi:10.1080/09205063.2018.148361629851539
   PubMed Web of Science ®Google Scholar
• Pei Q, Hu X, Zhou J, et al. Glutathione-responsive paclitaxel dimer nanovesicles with high drug content. Biomater Sci. 2017;5(8):1517–1521. doi:10.1039/c7bm00052a28191576
   PubMedGoogle Scholar
• Oropeza-Guzman E, Ruiz-Suárez JC. Dehydration/rehydration cycles for mixing phospholipids without the use of organic solvents. Langmuir. 2018;34(23):6869–6873. doi:10.1021/acs.langmuir.8b0079929779384
   PubMedGoogle Scholar
• Al-Asmari AK, Ullah Z, Al Balowi A, et al. In vitro determination of the efficacy of scorpion venoms as anti-cancer agents against colorectal cancer cells: a nano-liposomal delivery approach. Int J Nanomedicine. 2017;12:559–574. doi:10.2147/IJN.S12351428144138
   PubMed Web of Science ®Google Scholar
• Niu D, Wang X, Li Y, et al. Facile synthesis of magnetite/perfluorocarbon co-loaded organic/inorganic hybrid vesicles for dual-modality ultrasound/magnetic resonance imaging and imaging-guided high-intensity focused ultrasound ablation. Adv Mater. 2013;25(19):2686–2692. doi:10.1002/adma.20120431623447424
   PubMed Web of Science ®Google Scholar
• Seleci M, Ag Seleci D, Scheper T, et al. Theranostic liposome-nanoparticle hybrids for drug delivery and bioimaging. Int J Mol Sci. 2017;18(7):E1415. doi:10.3390/ijms1807141528671589
   PubMed Web of Science ®Google Scholar
• McNicholas K, Michael MZ. Immuno-characterization of exosomes using nanoparticle tracking analysis. Methods Mol Biol. 2017;1545:35–42. doi:10.1007/978-1-4939-6728-5_327943205
   PubMedGoogle Scholar
• Park YH, Lee DH, Um E, et al. On-chip generation of monodisperse giant unilamellar lipid vesicles containing quantum dots. Electrophoresis. 2016;37(10):1353–1358. doi:10.1002/elps.20160003526920999
   PubMedGoogle Scholar
• Xu X, Song R, He M, et al. Microfluidic production of nanoscale perfluorocarbon droplets as liquid contrast agents for ultrasound imaging. Lab Chip. 2017;17(20):3504–3513. doi:10.1039/c7lc00056a28933795
   PubMedGoogle Scholar
• Samadikhah HR, Nikkhah M, Hosseinkhani S. Enhancement of cell internalization and photostability of red and green emitter quantum dots upon entrapment in novel cationic nanoliposomes. Luminescence. 2017;32(4):517–528. doi:10.1002/bio.320727767252
   PubMedGoogle Scholar
• Al-Ahmady ZS, Hadjidemetriou M, Gubbins J, et al. Formation of protein corona in vivo affects drug release from temperature-sensitive liposomes. J Control Release. 2018;276:157–167. doi:10.1016/j.jconrel.2018.02.03829522832
   PubMed Web of Science ®Google Scholar
• Wang L, Wang Y, Sun X, et al. Versatile self-assembly and biosensing applications of DNA and carbon quantum dots coordinated cerium ions. Chemistry. 2017;23(43):10413–10422. doi:10.1002/chem.20170170928580665
   PubMedGoogle Scholar
• Kim HJ, Oh SC. Novel systemic therapies for advanced gastric cancer. J Gastric Cancer. 2018;18(1):1–19. doi:10.5230/jgc.2018.18.e329629216
   PubMed Web of Science ®Google Scholar
• Liang G, Kan S, Zhu Y, et al. Engineered exosome-mediated delivery of functionally active miR-26a and its enhanced suppression effect in HepG2 cells. Int J Nanomedicine. 2018;13:585–599. doi:10.2147/IJN.S15445829430178
   PubMed Web of Science ®Google Scholar
• Gromov P, Gromova I. Characterization of the tumor secretome from Tumor Interstitial Fluid (TIF). Methods Mol Biol. 2016;1459:231–247. doi:10.1007/978-1-4939-3804-9_1627665563
   PubMedGoogle Scholar
• Liu H, Chen W, Zhi X, et al. Tumor-derived exosomes promote tumor self-seeding in hepatocellular carcinoma by transferring miRNA-25-5p to enhance cell motility. Oncogene. 2018;37(36):4964–4978. doi:10.1038/s41388-018-0309-x29786077
   PubMedGoogle Scholar
• Chiba M, Watanabe N, Watanabe M, et al. Exosomes derived from SW480 colorectal cancer cells promote cell migration in HepG2 hepatocellular cancer cells via the mitogen-activated protein kinase pathway. Int J Oncol. 2016;48(1):305–312. doi:10.3892/ijo.2015.325526647805
   PubMedGoogle Scholar
• Tanaka M, Ishikawa S, Ushiku T, et al. EVI1 modulates oncogenic role of GPC1 in pancreatic carcinogenesis. Oncotarget. 2017;8(59):99552–99566. doi:10.18632/oncotarget.2060129245923
   PubMedGoogle Scholar